欧美综合自拍亚洲综合网_欧美黑人巨大videos异族_可乐操中文字幕_亚洲成av人福利专区网站_国产强奸视频在播放_免费无码国产在线53_最近最新的免費中文字幕_抖音免费视频素材_亚洲精品熟女一二区_国产无套粉嫩白浆在线麻豆

纖溶酶原激活物抑制因子1(PAI1)多克隆抗體(生物素標(biāo)記)

Biotin-Linked Polyclonal Antibody to Plasminogen Activator Inhibitor 1 (PAI1)

SERPINE1; PLANH1; Serpin Peptidase Inhibitor Clade E Member 1; Nexin,Plasminogen Activator Inhibitor Type 1 Serpin E1; Endothelial plasminogen activator inhibitor

  • 纖溶酶原激活物抑制因子1(PAI1)多克隆抗體(生物素標(biāo)記) 產(chǎn)品包裝(模擬)
  • 纖溶酶原激活物抑制因子1(PAI1)多克隆抗體(生物素標(biāo)記) 產(chǎn)品包裝(模擬)
  • Certificate 通過ISO 9001、ISO 13485質(zhì)量體系認(rèn)證

特異性

該抗體是針對PAI1的兔多克隆抗體。在免疫組織化學(xué)染色和免疫印跡實(shí)驗(yàn)中能識別PAI1。

用法

免疫印跡：0.2-2μg/mL;1:250-2500
免疫組織化學(xué)：5-20μg/mL;1:25-100
免疫細(xì)胞化學(xué)：5-20μg/mL;1:25-100
最佳稀釋倍數(shù)最終由用戶決定。

儲存

經(jīng)常使用則4°C保存。-20°C保存不超過兩年。避免反復(fù)凍融。

穩(wěn)定性

熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗(yàn)決定，具體方法如下：在37°C孵育48小時，沒有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi)，在適當(dāng)?shù)臈l件下存儲，損失率低于5%。

贈品

相關(guān)產(chǎn)品

編號 適用物種：Homo sapiens (Human，人) 應(yīng)用(僅供研究使用，不用于臨床診斷！)
RPA532Hu02 纖溶酶原激活物抑制因子1(PAI1)重組蛋白 Positive Control; Immunogen; SDS-PAGE; WB.
EPA532Hu61 纖溶酶原激活物抑制因子1(PAI1)真核蛋白 Positive Control; Immunogen; SDS-PAGE; WB.
RPA532Hu01 纖溶酶原激活物抑制因子1(PAI1)重組蛋白 Positive Control; Immunogen; SDS-PAGE; WB.
APA532Hu61 纖溶酶原激活物抑制因子1(PAI1)活性蛋白 Cell?culture;?Activity?Assays.
PAA532Hu01 纖溶酶原激活物抑制因子1(PAI1)多克隆抗體 WB; IHC; ICC; IP.
PAA532Hu02 纖溶酶原激活物抑制因子1(PAI1)多克隆抗體 WB; IHC; ICC; IP.
LAA532Hu71 纖溶酶原激活物抑制因子1(PAI1)多克隆抗體(生物素標(biāo)記) WB; IHC; ICC.
LAA532Hu81 纖溶酶原激活物抑制因子1(PAI1)多克隆抗體(異硫氰酸熒光素標(biāo)記) WB; IHC; ICC; IF.
MAA532Hu22 纖溶酶原激活物抑制因子1(PAI1)單克隆抗體 WB; IHC; ICC/IF
MAA532Hu24 纖溶酶原激活物抑制因子1(PAI1)單克隆抗體 WB; IHC; ICC; IP.
MAA532Hu27 纖溶酶原激活物抑制因子1(PAI1)單克隆抗體 WB; IHC; ICC; IP.
MAA532Hu29 纖溶酶原激活物抑制因子1(PAI1)單克隆抗體 WB; IHC; ICC; IP.
MAA532Hu25 纖溶酶原激活物抑制因子1(PAI1)單克隆抗體 WB; IHC; ICC; IP.
MAA532Hu21 纖溶酶原激活物抑制因子1(PAI1)單克隆抗體 WB; IHC; ICC; IP.
MAA532Hu26 纖溶酶原激活物抑制因子1(PAI1)單克隆抗體 WB; IHC; ICC; IP.
MAA532Hu28 纖溶酶原激活物抑制因子1(PAI1)單克隆抗體 WB; IHC; ICC; IP.
MAA532Hu23 纖溶酶原激活物抑制因子1(PAI1)單克隆抗體 WB; IHC
FAA532Hu04 抗纖溶酶原激活物抑制因子1(PAI1)單克隆抗體 Flow cytometry.
FAA532Hu02 抗纖溶酶原激活物抑制因子1(PAI1)單克隆抗體 Flow cytometry.
FAA532Hu06 抗纖溶酶原激活物抑制因子1(PAI1)單克隆抗體 Flow cytometry.
FAA532Hu08 抗纖溶酶原激活物抑制因子1(PAI1)單克隆抗體 Flow cytometry.
LAA532Hu74 纖溶酶原激活物抑制因子1(PAI1)單克隆抗體(生物素標(biāo)記) WB; IHC; ICC.
LAA532Hu76 纖溶酶原激活物抑制因子1(PAI1)單克隆抗體(生物素標(biāo)記) WB; IHC; ICC.
MEA532Hu 纖溶酶原激活物抑制因子1(PAI1)檢測試劑盒(酶聯(lián)免疫吸附試驗(yàn)法,小樣本) Enzyme-linked immunosorbent assay for Antigen Detection.
SEA532Hu 纖溶酶原激活物抑制因子1(PAI1)檢測試劑盒(酶聯(lián)免疫吸附試驗(yàn)法) Enzyme-linked immunosorbent assay for Antigen Detection.
SCA532Hu 纖溶酶原激活物抑制因子1(PAI1)檢測試劑盒(化學(xué)發(fā)光免疫分析法) Chemiluminescent immunoassay for Antigen Detection.
LMA532Hu 纖溶酶原激活物抑制因子1(PAI1)等多因子檢測試劑盒(流式熒光發(fā)光法) FLIA Kit for Antigen Detection.
PSA532Hu01 纖溶酶原激活物抑制因子1(PAI1)抗體對 ELISA; CLIA; ELISPOT; Luminex; Immunochromatography and other Immunoassays.
KSA532Hu01 纖溶酶原激活物抑制因子1(PAI1)檢測試劑盒DIY材料(酶聯(lián)免疫吸附試驗(yàn)法) Main materials for "Do It (ELISA Kit) Yourself".

參考文獻(xiàn)

雜志 參考文獻(xiàn)
Breast Cancer Research and Treatment Oral administration of benzyl-isothiocyanate inhibits solid tumor growth and lung metastasis of 4T1 murine mammary carcinoma cells in BALB/c mice [SpringerLink: f3w831267267p277]
Clin Appl Thromb Hemost. Is There Any Association Between Thrombosis and Tissue Factor Pathway Inhibitor Levels in Patients With Vitamin D Deficiency? [Pubmed: 24203351]
Molecular Nutrition & Food Research Trans‐fatty acid promotes thrombus formation in mice by aggravating antithrombogenic endothelial functions via Toll‐like receptors [PubMed: 25546502]
Archives of Physiology and Biochemistry Activation of cardiac renin–angiotensin system and plasminogen activator inhibitor-1 gene expressions in oral contraceptive-induced cardiometabolic disorder [Pubmed:26934364]
Naunyn-Schmiedeberg's Archives of Pharmacology Combined oral contraceptive-induced hypertension is accompanied by endothelial dysfunction and upregulated intrarenal angiotensin II type 1 receptor gene expression [pubmed:27447455]
Environmental toxicology and pharmacology Combined oral contraceptive and nitric oxide synthesis inhibition synergistically causes cardiac hypertrophy and exacerbates insulin resistance in female rats. [pubmed:28376377]
Annals of Clinical & Laboratory Science Alteration of Hemostatic Parameters in Patients with Different Levels of Subclinical Hypothyroidism and the Effect of L-thyroxine Treatment [pubmed:28249913]
Pharmacological reports Anti-inflammatory and antithrombotic effects of nicotine exposure in oral contraceptive-induced insulin resistance are glucocorticoid-independent [pubmed:28349880]
Haematologica Cytoprotective and pro-angiogenic functions of thrombomodulin are preserved in the C loop of the fifth epidermal growth factor-like domain [Pubmed:29903766]
Biomedicine & Pharmacotherapy Puerarin prevents vascular endothelial injury through suppression of NF-κB activation in LPS-challenged human umbilical vein endothelial cells [Pubmed:29775893]
Archives of?Physical?Medicine?and Rehabilitation Impact of Regular Physical Activity on Adipocytokines and Cardiovascular Characteristics in Spinal Cord–Injured Subjects [Pubmed:29548578]
Marine Drugs Anticoagulant and Antithrombotic Properties in Vitro and in Vivo of a Novel Sulfated Polysaccharide from Marine Green Alga Monostroma nitidum [Pubmed: 31027312]
Experimental and Therapeutic Medicine IKKβ regulates the expression of coagulation and fibrinolysis factors through the NF?κB canonical pathway in LPS?stimulated alveolar epithelial cells type II [Pubmed: 31572531]
Phytomedicine Sodium aescinate significantly suppress postoperative peritoneal adhesion by inhibiting the RhoA/ROCK signaling pathway [Pubmed: 32120245]
Sci Rep Fibroblast growth factor-21 as a novel metabolic factor for regulating thrombotic homeostasis [Pubmed:35013379]
Phytomedicine Multi-omics analysis reveals the mechanisms of action and therapeutic regimens of traditional Chinese medicine, Bufei Jianpi granules: Implication for COPD drug?… [Pubmed:35121390]
留言咨詢